ID   QHJI14s04
AC   CVCL_C1DN
SY   QHJI 14s04
DR   Wikidata; Q114312753
RX   PubMed=31497180;
RX   PubMed=35304548;
RX   PubMed=36395757;
WW   https://www.cira-foundation.or.jp/assets/file/homozygous/1_qhji/QHJI14s04_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (CiRA).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DX ! Ff-I01s01
OI   CVCL_C1DY ! Ff-I01s04
OI   CVCL_C1DZ ! Ff-I14s03
OI   CVCL_C1DM ! Ff-I14s04
OI   CVCL_C1E0 ! QHJI01s01
OI   CVCL_C1E1 ! QHJI01s04
OI   CVCL_C1E2 ! QHJI14s03
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 5
//
RX   PubMed=31497180; DOI=10.1186/s41232-019-0106-0;
RA   Umekage M., Sato Y., Takasu N.;
RT   "Overview: an iPS cell stock at CiRA.";
RL   Inflamm. Regen. 39:17.1-17.5(2019).
//
RX   PubMed=35304548; DOI=10.1038/s41598-022-08753-5;
RA   Hiyoshi H., Sakuma K., Tsubooka-Yamazoe N., Asano S., Mochida T.,
RA   Yamaura J., Konagaya S., Fujii R., Matsumoto H., Ito R., Toyoda T.;
RT   "Characterization and reduction of non-endocrine cells accompanying
RT   islet-like endocrine cells differentiated from human iPSC.";
RL   Sci. Rep. 12:4740-4740(2022).
//
RX   PubMed=36395757; DOI=10.1016/j.medj.2022.10.003;
RA   Yoshida S., Kato T.M., Sato Y., Umekage M., Ichisaka T., Tsukahara M.,
RA   Takasu N., Yamanaka S.;
RT   "A clinical-grade HLA haplobank of human induced pluripotent stem
RT   cells matching approximately 40% of the Japanese population.";
RL   Med 4:51-66.e10(2023).
//